Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy

QR Code

Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy

In spite of significant advances in treatment options and the advent of novel targeted therapies, there still remains an unmet need for the identification of novel pharmacological agents for cancer therapy. This has led to several studies evaluating the possible application of natural agents found i...

Full description

Bibliographic Details
Main Authors:	Ko, J., Arfuso, Frank, Sethi, G., Ahn, K.
Format:	Journal Article
Published:	MDPI AG 2018
Online Access:	http://hdl.handle.net/20.500.11937/74245

Similar Items

The role of resveratrol in cancer therapy
by: Ko, J., et al.
Published: (2017)

Targeting transcription factor STAT3 for cancer prevention and therapy.
by: Chai, E., et al.
Published: (2015)

NF-κB in cancer therapy
by: Li, F., et al.
Published: (2015)

Triterpenoids and sesquiterpenoids for prostate cancer therapy
by: Shanmugam, M., et al.
Published: (2016)

Extraction and characterization of pectin from grapefruit (Duncan cultivar) and its utilization as gelling agent
by: Khan, Ammar Ahmed, et al.
Published: (2014)

Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds
by: Shanmugam, M., et al.
Published: (2015)

Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: Preclinical and clinical evidence
by: Shanmugam, M., et al.
Published: (2014)

Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
by: Dai, X., et al.
Published: (2015)

Potential anti-inflammatory and anti-cancer properties of farnesol
by: Jung, Y., et al.
Published: (2018)

Possible use of Punica granatum (Pomegranate) in cancer therapy
by: Khwairakpam, A., et al.
Published: (2018)

Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy
by: Min-Wen, J., et al.
Published: (2017)

The multifaceted role of curcumin in cancer prevention and treatment
by: Shanmugam, M., et al.
Published: (2015)

Potential application of zerumbone in the prevention and therapy of chronic human diseases
by: Singh, Y., et al.
Published: (2019)

Potential role of genipin in cancer therapy
by: Shanmugam, M., et al.
Published: (2018)

Development and quality evaluation of cookies enriched with various levels of grapefruit pomace powder
by: Kausar, Tusneem, et al.
Published: (2024)

Colon cancer chemoresistance and chemosensitization
by: Shanmugam, M., et al.
Published: (2018)

Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer
by: Shanmugam, M., et al.
Published: (2012)

Current research on pharmacologic and regenerative therapies for osteoarthritis
by: Zhang, W., et al.
Published: (2016)

Analysis of the intricate relationship between chronic inflammation and cancer
by: Chai, E., et al.
Published: (2015)

Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
by: Guo, Q., et al.
Published: (2018)

The future of osteoarthritis therapeutics: targeted pharmacological therapy
by: Mobasheri, Ali
Published: (2013)

Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance
by: Raghunath, A., et al.
Published: (2018)

Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
by: Shanmugam, M., et al.
Published: (2017)

Role of RNF20 in cancer development and progression – a comprehensive review
by: Sethi, G., et al.
Published: (2018)

Comprehending the pharmacological mechanism of marine phenolic acids in bladder cancer therapy against matrix metalloproteinase 9 protein by integrated network pharmacology and in-silico approaches
by: Roney, Miah, et al.
Published: (2024)

Molecular targets modulated by fangchinoline in tumor cells and preclinical models
by: Mérarchi, M., et al.
Published: (2018)

Role of novel histone modifications in cancer
by: Shanmugam, M., et al.
Published: (2018)

Silica-supported ionic liquid-based dispersive microextraction of grapefruit peel flavonoid (hesperidin) and assessment of its antioxidant activities
by: Waheed, Ammara, et al.
Published: (2025)

Cancer stem cell metabolism: A potential target for cancer therapy
by: Deshmukh, A., et al.
Published: (2016)

Molecular targets and anti-cancer potential of escin
by: Cheong, D., et al.
Published: (2018)

Targeting PPARy signaling cascade for the prevention and treatment of prostate cancer
by: Sikka, S., et al.
Published: (2012)

Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
by: Danic, M., et al.
Published: (2018)

Do STAT3 inhibitors have potential in the future for cancer therapy?
by: Wong, A., et al.
Published: (2017)

Evidence for the Involvement of the Master Transcription Factor NF-?B in Cancer Initiation and Progression.
by: Puar, Y., et al.
Published: (2018)

Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
by: Manu, K., et al.
Published: (2018)

Oleuropein induces apoptosis via abrogating NF-?B activation cascade in estrogen receptor–negative breast cancer cells
by: Liu, L., et al.
Published: (2018)

Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer
by: Ranaware, A., et al.
Published: (2018)

Correction: Role of novel histone modifications in cancer [Oncotarget, 9, (2018), (11414-11426)] doi 10.18632/oncotarget.23356
by: Shanmugam, M., et al.
Published: (2018)

The potential role of boswellic acids in cancer prevention and treatment
by: Roy, N., et al.
Published: (2016)

Pharmacological modulation of apoptosis and autophagy in pancreatic cancer treatment
by: Stanslas, Johnson, et al.
Published: (2022)